Gilbert Zeanandin
University of Nice Sophia Antipolis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gilbert Zeanandin.
Inflammatory Bowel Diseases | 2008
Stéphane M. Schneider; Rima Al-Jaouni; Jérôme Filippi; Jean‐Baptiste Wiroth; Gilbert Zeanandin; Kamel Arab; Xavier Hébuterne
Background: Patients with Crohns disease (CD) are prone to osteoporosis. A loss of muscle mass, called sarcopenia, is responsible for an increased risk of disability. Many factors associated with osteopenia also decrease muscle mass. The aim of the present study was to measure the prevalence of sarcopenia in CD patients in remission and uncover its relationship with osteopenia. Methods: In all, 82 CD patients (43 female / 39 male; 36 ± 14 years; body mass index [BMI] 21.1 ± 3.4) and 50 healthy volunteers (30F/20M; 39 ± 13 years; BMI 22.2 ± 2.5) were studied. Body composition was assessed using dual‐energy x‐ray absorptiometry. Sarcopenia was defined as an appendicular skeletal muscle index (ASMI) below 5.45 kg/m2 for women and 7.26 for men. Osteopenia was defined as a T‐score for bone mineral density (BMD) (g/cm2) below −1.0. Results: In all, 60% of CD patients were found to be sarcopenic and 30% osteopenic, compared to 16% and 4% of controls, respectively (P < 0.01). ASMI was significantly lower in patients than in controls (6.0 ± 1.1 versus 6.5 ± 1.2; P < 0.05). Sarcopenic patients had significantly (P < 0.01) lower BMI (20.0 ± 3.5 versus 22.7 ± 2.8 kg/m2), lean mass (41.5 ± 9.1 versus 48.1 ± 9.1 kg), and BMD (1.09 ± 0.12 versus 1.15 ± 0.08 g/cm2) than nonsarcopenic patients; 91% of sarcopenic patients were also osteopenic. ASMI correlated with BMD (r = 0.46; P < 0.01) and BMI (r = 0.38; P < 0.01). Conclusions: The prevalence of sarcopenia is high in young CD patients and strongly related to osteopenia. These 2 phenomena may share similar mechanisms. Simultaneous screening for sarcopenia and osteopenia may be useful in CD patients.
Journal of Parenteral and Enteral Nutrition | 2017
E. Gyan; Bruno Raynard; Jean-Philippe Durand; Jean Lacau Saint Guily; Sebastien Gouy; Marie Lespiau Movschin; Faiza Khemissa; Nicolas Flori; Sandrine Oziel-Taieb; Cécile Bannier Braticevic; Gilbert Zeanandin; Christophe Hebert; Francesco Savinelli; François Goldwasser; Xavier Hébuterne
BACKGROUND Malnutrition is a critical predictor of toxicity and outcome in patients with cancer and may be perceived differently by patients, relatives, and physicians. AIMS To assess the prevalence of malnutrition in oncology departments and to compare it with the perceptions of nutrition status by patients themselves, their closest relatives, and attending physicians. MATERIALS AND METHODS A 1-day multicentric cross-sectional survey on the prevalence of malnutrition was conducted in different oncology departments using patient-, relative-, and physician-specific questionnaires. Malnutrition was defined by a weight loss ≥5% within 1 month or ≥10% within 6 months, a body mass index ≤18.5 kg/m2 in patients aged <70 years or ≤21 kg/m2 in patients aged ≥70 years, and/or albuminemia <35 g/L. Questionnaires for assessing medical condition, knowledge of nutrition status, and perceptions of the impact of malnutrition on daily life were distributed to consenting patients, attending physicians, and closest relatives. RESULTS A total of 2197 patients were included, and 2071 and 976 questionnaires were collected from patients and relatives, respectively. Prevalence of malnutrition was 39%. Physicians overestimated malnutrition (44%), whereas patients and relatives underestimated it (22% and 23%, respectively, P < .001). Conversely, malnutrition-associated symptoms were underestimated by physicians compared with patients and relatives. CONCLUSION We found a prevalence of malnutrition of 39%: it was underestimated by patients and relatives and overestimated by physicians.BACKGROUND Malnutrition is a critical predictor of toxicity and outcome in patients with cancer and may be perceived differently by patients, relatives, and physicians. AIMS To assess the prevalence of malnutrition in oncology departments and to compare it with the perceptions of nutrition status by patients themselves, their closest relatives, and attending physicians. MATERIALS AND METHODS A 1-day multicentric cross-sectional survey on the prevalence of malnutrition was conducted in different oncology departments using patient-, relative-, and physician-specific questionnaires. Malnutrition was defined by a weight loss ≥5% within 1 month or ≥10% within 6 months, a body mass index ≤18.5 kg/m2 in patients aged <70 years or ≤21 kg/m2 in patients aged ≥70 years, and/or albuminemia <35 g/L. Questionnaires for assessing medical condition, knowledge of nutrition status, and perceptions of the impact of malnutrition on daily life were distributed to consenting patients, attending physicians, and closest relatives. RESULTS A total of 2197 patients were included, and 2071 and 976 questionnaires were collected from patients and relatives, respectively. Prevalence of malnutrition was 39%. Physicians overestimated malnutrition (44%), whereas patients and relatives underestimated it (22% and 23%, respectively, P < .001). Conversely, malnutrition-associated symptoms were underestimated by physicians compared with patients and relatives. CONCLUSION We found a prevalence of malnutrition of 39%: it was underestimated by patients and relatives and overestimated by physicians.
Transplantation Proceedings | 2010
T. Yandza; Stéphane M. Schneider; S. Nishida; B. Goubaux; L. Badan; Geoffroy Vanbiervliet; Marie-Christine Saint-Paul; G. Bernard; C. Laffont; M. Gari-Toussaint; Fernand Girard-Pipau; V. Miton; Amine Rahili; Gilbert Zeanandin; Daniel Benchimol; A. Tzakis; Jean Gugenheim; X. Hébuterne
A 34-year-old-man with short-bowel syndrome received an isolated small bowel graft. On postoperative day (POD) 11, ileal biopsy specimen demonstrated mild to moderate rejection that did not respond to corticosteroid bolus therapy. On POD 14, endoscopy and histologic examination revealed exfoliative rejection that was not controlled after 14 days of therapy with thymoglobulin. On POD 95, the patient underwent surgery again because of intestinal obstruction. The graft was removed 6 months after transplantation because of continuous severe abdominal pain with weight loss. After enterectomy, the patient developed multiple-organ failure and died on POD day 8. This case underlines the severity of exfoliative rejection and suggests that early enterectomy be performed when the diagnosis is made, before deterioration of clinical status and development of infectious and nutritional complications.
Transplantation Proceedings | 2010
Thierry Yandza; Stéphane M. Schneider; S. Novellas; L. Badan; Marie-Christine Saint-Paul; P.A. Bounin; Amine Rahili; Gilbert Zeanandin; Daniel Benchimol; Jean Gugenheim; X. Hébuterne
We report the case of a 62-year-old man with short-bowel syndrome, referred for intestinal transplantation, who had esophageal varices (EV) due to superior vena cava (SVC) thrombosis. Pretransplantation work-up revealed protein S deficiency. Results of liver function tests were normal. Upper endoscopy showed grade II to III EV in the upper and middle segments of the esophagus. Computed tomography demonstrated thrombosis of the jugular, subclavian, and SVC veins and marked collateral vessels in the chest. Transient elastography yielded normal findings. A liver biopsy specimen showed a normal aspect of the liver, without fibrosis or liver cirrhosis. Presence of EV in a patient with chronic intestinal insufficiency may be related to collateral venous circulation associated with SVC thrombosis in the absence of portal hypertension. In this situation, an isolated intestinal graft is indicated.
Age | 2012
Gilbert Zeanandin; Michèle Balage; Stéphane M. Schneider; Joëlle Dupont; Xavier Hébuterne; Isabelle Mothe-Satney; Dominique Dardevet
Clinical Nutrition | 2012
Gilbert Zeanandin; Omar Molato; Franck Le Duff; Olivier Guérin; Xavier Hébuterne; Stéphane M. Schneider
Nutrition Clinique Et Metabolisme | 2014
Dominique Caldari; R. Hankard; Arnaud de Luca; N. Peretti; Ronan Thibault; Patrick Bachmann; Pauline Coti; Esther Guex; Gilbert Zeanandin; Didier Quilliot
/data/revues/09850562/v26i1/S0985056211001117/ | 2012
Gilbert Zeanandin; Stéphane M. Schneider; Xavier Hébuterne
Nutrition Clinique Et Metabolisme | 2008
Stéphane M. Schneider; Yves Boirie; Gilbert Zeanandin; Isabelle Mothe-Satney; Xavier Hébuterne
Nutrition Clinique Et Metabolisme | 2016
Gilbert Zeanandin; Ronan Thibault; Dominique Caldari; Pauline Coti; Esther Guex; Patrick Bachmann; Didier Quilliot